
INOVIO to present at two major healthcare investor conferences in September 2026
INOVIO, a biotechnology company specializing in DNA medicines for HPV-related diseases, cancer, and infectious diseases, announced its participation in two upcoming investor conferences in New York: the Cantor Global Healthcare Conference on Septembe...

